Proteomic Markers of Arteriosclerosis
Proteomic Markers of Arteriosclerosis
批准号:
6961229
负责人:
Iftikhar J Kullo
金额:
$93.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-12 至 2009-06-30
关键词:
African Americanalbuminsarteriosclerosisbiomarkercalcificationcalcium disordercardiovascular disorder diagnosiscaucasian Americanclinical researchcooperative studycoronary arterycreatininediagnosis design /evaluationearly diagnosishuman subjectinflammationlipid metabolismlongitudinal human studymagnetic resonance imagingoxidative stressproteomicssiblingsstatistics /biometrythrombosis
中文摘要
描述(由申请人提供):
申请者的长期目标是开发新的、有效的生物标记物,使血管疾病能够早期发现。美国有超过6500万人受到高血压的影响。脑、心、肾和外周动脉床的动脉硬化(即动脉粥样硬化和动脉硬化)在高血压的背景下加速,并导致靶器官损害和
心血管后遗症,如中风、心肌梗死、慢性肾功能不全和跛行。目前可用的风险评估工具灵敏度和特异度较差。验证动脉硬化性血管疾病的新生物标记物将有助于制定创新的预防和治疗策略,最终提高生活质量并降低死亡率。此应用程序建议调查
在非裔美国人(n=1150)和非西班牙裔白人(n=1150)中,炎症、血栓形成、脂蛋白代谢、血管重构和氧化应激途径中的50个候选蛋白质组标记与属于高血压兄弟姐妹的非裔美国人(n=1150)和非西班牙裔白人(n=1150)的动脉硬化的4种不同量化指标之间的关系,利用作为NHLBI家庭血压计划的一部分开发的优秀临床研究基础设施。可用于该建议的动脉粥样硬化或大血管疾病的测量方法包括踝臂指数和冠状动脉钙化的数量。对于这一建议,可用的动脉硬化性或微血管疾病的衡量标准包括通过脑部磁共振成像和尿白蛋白/肌酐比率评估的脑白质疏松。我们将完成以下具体目标:具体目标1:我们将为50个候选蛋白质组标记建立可靠的验证方法,并使用验证后的方法,对两个民族队列中的2300名受试者进行蛋白质组标记的测量。我们还将开发和验证用于多重分析的6-8个标记物的面板。具体目标2:我们将使用各种统计方法,包括主成分因子分析和(贝叶斯和非贝叶斯)模型平均,以确定(从50个蛋白质组标记中)对属于两个种族队列的2300名受试者的4个动脉硬化定量指标中的每一个的最佳预测模型。
英文摘要
DESCRIPTION (provided by applicant):
The long term goal of the applicant is to develop new, validated biomarkers that will enable early detection of vascular disease. More than 65 million people in the United States are affected by hypertension. Arteriosclerosis (i.e., atherosclerosis and arteriolosclerosis) of the cerebral, cardiac, renal, and peripheral arterial beds is accelerated in the setting of hypertension and leads to target organ damage and
cardiovascular sequelae such as stroke, myocardial infarction, chronic renal insufficiency, and claudication. Currently available risk assessment tools have poor sensitivity and specificity. Validating new biomarkers of arteriosclerotic vascular disease will allow formulation of innovative preventive and therapeutic strategies to ultimately improve quality-of-life and reduce mortality. This application proposes to investigate the
relationship of 50 candidate proteomic markers in pathways of inflammation, thrombosis, lipoprotein metabolism, vascular remodeling, and oxidative stress to 4 different quantitative measures of arteriosclerosis in African American (n = 1150) and non-Hispanic white (n = 1150) individuals belonging to hypertensive sibships, leveraging the excellent clinical research infrastructure developed as part of the NHLBI's Family Blood Pressure Program. The measures of atherosclerotic or 'macrovascular' disease available for this proposal include the ankle-brachial index and quantity of coronary artery calcification. The measures of arteriolosclerotic or 'microvascular' disease available for this proposal include cerebral leukoaraiosis assessed by magnetic resonance imaging of the brain and urinary albumin-creatinine ratio. We will accomplish the following specific aims: Specific Aim 1: We will develop robust validated assays for 50 candidate proteomic markers and using the validated assays, measure the proteomic markers in 2300 subjects belonging to the two ethnic cohorts. We will also develop and validate panels of 6-8 markers for multiplex assays. Specific Aim 2: We will use a variety of statistical approaches including Principal Components Factor Analysis and (Bayesian and non-Bayesian) model-averaging to identify the best predictive models (from among the 50 proteomic markers) for each of the 4 quantitative measures of arteriosclerosis in the 2300 subjects belonging to the two ethnic cohorts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polygenic Risk of Disease in Populations of Diverse Ancestry
-
批准号:10210804
-
项目类别:
-
资助金额:$68.54万
-
财政年份:2021
-
负责人:Iftikhar J Kullo
-
依托单位:
Polygenic Risk of Disease in Populations of Diverse Ancestry
-
批准号:10670372
-
项目类别:
-
资助金额:$60.41万
-
财政年份:2021
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia
-
批准号:9389934
-
项目类别:
-
资助金额:$52.01万
-
财政年份:2017
-
负责人:Iftikhar J Kullo
-
依托单位:
Patient-Oriented Research in Genomic Discovery and Implementation
-
批准号:10221769
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2017
-
负责人:Iftikhar J Kullo
-
依托单位:
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients
-
批准号:8467044
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2012
-
负责人:Iftikhar J Kullo
-
依托单位:
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients
-
批准号:8262563
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2012
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation
-
批准号:10469667
-
项目类别:
-
资助金额:$125.59万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
Genomic Basis of Susceptibility to COVID-19 Infection and its Complications
-
批准号:10165210
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation
-
批准号:10207706
-
项目类别:
-
资助金额:$127.3万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation (Pediatric Participants Supplement)
-
批准号:10849461
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation
-
批准号:10674944
-
项目类别:
-
资助金额:$113.69万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation (Bioethics Supplement)
-
批准号:10786522
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation
-
批准号:9481916
-
项目类别:
-
资助金额:$9.87万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation
-
批准号:9134797
-
项目类别:
-
资助金额:$84.94万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
EHR-based Genomic Discovery and Implementation (Supplement)
-
批准号:10835712
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2011
-
负责人:Iftikhar J Kullo
-
依托单位:
Determinants of arterial function in hypertension
-
批准号:7894699
-
项目类别:
-
资助金额:$73.94万
-
财政年份:2009
-
负责人:Iftikhar J Kullo
-
依托单位:
Determinants of arterial function in hypertension
-
批准号:7458604
-
项目类别:
-
资助金额:$74.02万
-
财政年份:2009
-
负责人:Iftikhar J Kullo
-
依托单位:
FUNCTIONAL ARTERIAL CHANGES IN ATHEROGENESIS
-
批准号:7206126
-
项目类别:
-
资助金额:$10.57万
-
财政年份:2005
-
负责人:Iftikhar J Kullo
-
依托单位:
Proteomic Markers of Arteriosclerosis
-
批准号:7456588
-
项目类别:
-
资助金额:$87.48万
-
财政年份:2005
-
负责人:Iftikhar J Kullo
-
依托单位:
Proteomic Markers of Arteriosclerosis
-
批准号:7253303
-
项目类别:
-
资助金额:$87.01万
-
财政年份:2005
-
负责人:Iftikhar J Kullo
-
依托单位:
海外基金